SCHEMBL698337

SCHEMBL698337

CN(C)CCOc1ccc(/N=C2/NC(=O)/C(=C/c3cnc(NC(=O)C4CC4)s3)S2)c(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 2/20 0.36
DUSP3 P51452 2/20 0.36
PTPN12 Q05209 2/20 0.36
PTPN22 Q9Y2R2 2/20 0.36
ABL1 P00519 3/20 0.35
CHRM5 P08912 1/20 0.34
GPR35 Q9HC97 1/20 0.34
MAPT P10636 3/20 0.33
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33
RECQL P46063 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RNASEL Q05823 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649652 0.92 RNASEL (0.40) ABL1HPGDRNASELTUBB4ATUBB
SCHEMBL652415 0.92 MAPT (0.41) PTPN7DUSP3PTPN12PTPN22ABL1
SCHEMBL703259 0.91 MEN1 (0.38) PTPN7PTPN12PTPN22MAPTHPGD
SCHEMBL653897 0.88 MAPT (0.40) PTPN7DUSP3PTPN12PTPN22ABL1
SCHEMBL653900 0.88 MAPT (0.45) PTPN7DUSP3PTPN12PTPN22MAPT
SCHEMBL651683 0.85 MAPT (0.40) PTPN7DUSP3PTPN12PTPN22ABL1
SCHEMBL653370 0.85 MAPT (0.40) PTPN7DUSP3PTPN12PTPN22ABL1
SCHEMBL652215 0.84 HPGD (0.36) PTPN7DUSP3PTPN12PTPN22ABL1
SCHEMBL650980 0.84 MAPT (0.42) PTPN7DUSP3PTPN12PTPN22MAPT
SCHEMBL650979 0.84 MAPT (0.42) PTPN7DUSP3PTPN12PTPN22MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423204-A1 THIAZOLIDINONE DERIVATIVE SBI Biotech Co., Ltd. (JP) 2012-02-29 EP disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 PTPN7 437/4885DUSP3 579/4885PTPN12 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.